The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases

被引：0
|
作者：
Breanne Lechner
Carlo DeAngelis
Noreen Jamal
Urban Emmenegger
Natalie Pulenzas
Angie Giotis
Parker Sheehan
May Tsao
Gillian Bedard
Edward Chow
机构：
[1] University of Toronto,Rapid Response Radiotherapy Program, Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[2] University of Toronto,Department of Pharmacy, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[3] University of Toronto,Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Denosumab; Hypocalcemia; Bone metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1765 / 1771
页数：6
相关论文
共 50 条
  • [31] Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases
    Hibiki Udagawa
    Seiji Niho
    Keisuke Kirita
    Shigeki Umemura
    Shingo Matsumoto
    Kiyotaka Yoh
    Koichi Goto
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1075 - 1082
  • [32] Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab
    Loyson, Tine
    Van Cann, Thomas
    Schoffski, Patrick
    Clement, Paul M.
    Bechter, Oliver
    Spriet, Isabel
    Coropciuc, Ruxandra
    Politis, Constantinus
    Vandeweyer, Raf O.
    Schoenaers, Joseph
    Dumez, Herlinde
    Berteloot, Patrick
    Neven, Patrick
    Nackaerts, Kristiaan
    Woei-A-Jin, Feng J. S. H.
    Punie, Kevin
    Wildiers, Hans
    Beuselinck, Benoit
    ACTA CLINICA BELGICA, 2018, 73 (02) : 100 - 109
  • [33] Population pharmacokinetic analysis of denosumab in Patients with Bone Metastases from Solid Tumours
    Gibiansky L.
    Sutjandra L.
    Doshi S.
    Zheng J.
    Sohn W.
    Peterson M.C.
    Jang G.R.
    Chow A.T.
    Pérez-Ruixo J.J.
    Clinical Pharmacokinetics, 2012, 51 (4) : 247 - 260
  • [34] Analysis of Denosumab on Skeletal-Related Events in Patients With Advanced Breast Cancer
    Bink, Kristen F.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (05) : E108 - E114
  • [35] An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer
    Liede, Alexander
    Hernandez, Rohini K.
    Wade, Sally W.
    Bo, Ronghai
    Nussbaum, Nathan C.
    Ahern, Elizabeth
    Dougall, William C.
    Smyth, Mark J.
    ONCOIMMUNOLOGY, 2018, 7 (12):
  • [36] Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective study
    Abousaud, Aseala I.
    Barbee, Meagan S.
    Davis, Christine C.
    Caulfield, Sarah E.
    Wang, Zeyuan
    Boykin, Alexa
    Carthon, Bradley C.
    Gogineni, Keerthi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [37] Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience
    Hegemann, Miriam
    Bedke, Jens
    Stenzl, Arnulf
    Todenhoefer, Tilman
    THERAPEUTIC ADVANCES IN UROLOGY, 2017, 9 (3-4) : 81 - 88
  • [38] Targeted treatments of bone metastases in patients with lung cancer
    Hirsh, Vera
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [39] Optimal management of bone metastases in breast cancer patients
    Wong, M. H.
    Pavlakis, N.
    BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 35 - 60
  • [40] Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism
    Daichi Miyaoka
    Yasuo Imanishi
    Eiko Kato
    Norikazu Toi
    Yuki Nagata
    Masafumi Kurajoh
    Shinsuke Yamada
    Masaaki Inaba
    Masanori Emoto
    Endocrine, 2020, 69 : 642 - 649
12345